V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000166 | 230000099 | 1.66 | 75.9 | Palliative (P) | 2013-07-12 | 2013-07-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | 230024159 | CAPECITABINE |
| 230000167 | 230000100 | 1.75 | 79.7 | Palliative (P) | 2018-07-04 | 2018-07-30 | CVP R | N | N | 230024182 | MEDROXYPROGESTERONE |
| 230000168 | 230000101 | null | 77.8 | Palliative (P) | null | 2015-07-21 | CAPECITABINE + OXALIPLATIN | N | N | 230024227 | OXALIPLATIN + MDG |
| 230000169 | 230001093 | 1.83 | 64.75 | Adjuvant (A) | 2017-12-09 | 2018-01-08 | Fluorouracil + Folinic Acid Weekly | N | N | 230024278 | FLUOROURACIL |
| 230000170 | 230001093 | 1.7 | 85 | Adjuvant (A) | null | 2014-01-21 | CARBOPLATIN | N | N | 230024278 | CAPECITABINE + OXALIPLATIN |
| 230000171 | 230001093 | 1.73 | 89 | Palliative (P) | 2014-06-30 | 2014-06-30 | CVP R | N | N | 230024278 | CAPECITABINE + MITOMYCIN |
| 230000172 | 230000102 | 1.68 | 74.6 | Palliative (P) | 2015-10-14 | 2015-10-18 | Oxaliplatin + Modified de Gramont | N | N | 230024406 | CAPECITABINE + OXALIPLATIN |
| 230000173 | 230000102 | 1.74 | 62.6 | Palliative (P) | 2015-09-06 | 2015-09-28 | Capecitabine + Oxaliplatin 21day | 02 | N | 230024406 | OXALIPLATIN + MDG |
| 230000174 | 230000103 | 1.78 | 67.9 | Adjuvant (A) | null | 2014-06-26 | Oxaliplatin + Modified de Gramont | N | Y | 230024456 | CAPECITABINE + OXALIPLATIN |
| 230000175 | 230000104 | 1.65 | 73.9 | Curative (C) | 2016-05-20 | 2016-06-11 | CAPECITABINE + MITOMYCIN + RT | 2 | N | 230024478 | CAPECITABINE + OXALIPLATIN |
| 230000176 | 230000105 | 1.57 | 94.5 | Adjuvant (A) | 2014-02-27 | 2014-03-06 | Azacitidine | 02 | N | 230024598 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 230000177 | 230000106 | 1.65 | 67.6 | Palliative (P) | 2017-10-23 | 2017-11-24 | SCOT TRIAL | N | N | 230024630 | CAPECITABINE + OXALIPLATIN |
| 230000178 | 230000107 | null | 72.8 | Not known (9) | 2015-10-12 | 2016-07-11 | Cisplatin + Vinorelbine (IV) | N | N | 230024662 | CAPECITABINE + MITOMYCIN + RT |
| 230000179 | 230001095 | 1.8 | 86.6 | Neo-adjuvant (N) | 2017-01-05 | 2017-01-05 | Sorafenib | 02 | N | 230024684 | IRINOTECAN + MDG |
| 230000180 | 230001095 | 1.63 | 77.9 | Palliative (P) | 2017-04-15 | 2017-04-15 | FEC 100 | 01 | N | 230024684 | CAPECITABINE + RT |
| 230000181 | 230001095 | 1.7 | 90.6 | Neo-adjuvant (N) | 2017-04-23 | 2017-04-30 | Oxaliplatin + Modified de Gramont | N | N | 230024684 | CAPECITABINE + OXALIPLATIN |
| 230000182 | 230001699 | 1.76 | 91.9 | Palliative (P) | 2017-08-01 | 2017-08-25 | Docetaxel 75mg/m2 (21 day) | N | N | 230024792 | FLUOROURACIL |
| 230000183 | 230001699 | 0.01 | null | Palliative (P) | 2014-10-10 | 2014-10-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 230024792 | OXALIPLATIN + MDG |
| 230000184 | 230001699 | 1.55 | 61.9 | Adjuvant (A) | 2017-04-09 | 2017-04-09 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 230024792 | CAPECITABINE + OXALIPLATIN |
| 230000185 | 230000108 | 1.46 | 94.6 | Curative (C) | 2012-12-24 | 2012-12-24 | Cisplatin + Doxorubicin | 02 | Y | 230025062 | CAPECITABINE + OXALIPLATIN |
| 230000186 | 230001096 | 1.7 | null | Adjuvant (A) | 2017-07-21 | 2017-07-21 | Capecitabine + Oxaliplatin 21day | N | N | 230025068 | CAPECITABINE + RT |
| 230000187 | 230000109 | 1.69 | 76 | Adjuvant (A) | 2014-03-04 | 2014-03-06 | Capecitabine + Oxaliplatin 21day | N | N | 230025074 | CAPECITABINE + OXALIPLATIN |
| 230000188 | 230000110 | 1.75 | 107 | Neo-adjuvant (N) | 2017-04-05 | 2017-04-09 | Docetaxel 75mg/m2 (21 day) | 2 | Y | 230025117 | CISPLATIN + FLUOROURACIL |
| 230000189 | 230000111 | 1.7 | 85.5 | Adjuvant (A) | 2017-08-25 | 2017-09-17 | Capecitabine | N | N | 230025296 | CAPECITABINE + OXALIPLATIN |
| 230000190 | 230000112 | null | 67.8 | Not known (9) | 2014-05-01 | 2014-05-12 | Capecitabine | N | null | 230025421 | CAPECITABINE + RT |
| 230000191 | 230001097 | 1.7 | 81 | Palliative (P) | null | 2018-11-21 | Irinotecan + Modified De Gramont | null | N | 230025511 | CABAZITAXEL |
| 230000192 | 230000113 | 1.61 | 68 | null | null | 2017-12-03 | CARBOPLATIN | 02 | N | 230025659 | IRINOTECAN + MDG |
| 230000193 | 230000114 | 1.74 | 113 | Palliative (P) | 2017-08-28 | 2017-08-29 | Trial Unspecified | 2 | N | 230025735 | CAPECITABINE |
| 230000194 | 230000114 | 1.65 | 88 | Palliative (P) | null | 2018-08-15 | Sorafenib | N | N | 230025735 | CAPECITABINE |
| 230000195 | 230000115 | 1.81 | 89 | Adjuvant (A) | 2015-04-15 | 2015-04-16 | Irinotecan + Modified De Gramont | 02 | N | 230025789 | CAPECITABINE + RT |
| 230000196 | 230000116 | 1.76 | 54.5 | Neo-adjuvant (N) | 2016-11-11 | 2016-11-11 | Cisplatin + Doxorubicin | 02 | N | 230025830 | CAPECITABINE |
| 230000197 | 230000117 | 1.61 | 64.5 | null | 2014-01-06 | 2014-01-06 | CARBOPLATIN + PACLITAXEL | N | null | 230025907 | CAPECITABINE |
| 230000198 | 230000118 | 1.73 | 96.5 | Neo-adjuvant (N) | 2016-04-13 | 2016-04-13 | Oxaliplatin + Modified de Gramont | 2 | N | 230025925 | CAPECITABINE + OXALIPLATIN |
| 230000199 | 230000119 | 1.61 | 61.9 | Palliative (P) | 2018-06-04 | 2018-06-06 | Cisplatin + Doxorubicin | N | N | 230025957 | CAPECITABINE + OXALIPLATIN |
| 230000200 | 230000120 | 0 | 68.7 | Palliative (P) | 2014-04-24 | 2014-05-03 | FLUOROURACIL + IRINOTECAN | N | N | 230026041 | CAPECITABINE + OXALIPLATIN |
| 230000201 | 230000120 | null | null | Neo-adjuvant (N) | null | 2014-07-21 | Cisplatin +Fluorouracil (3 wk) | null | N | 230026041 | FLUOROURACIL + MITOMYCIN + RT |
| 230000202 | 230000120 | 0 | 69 | Neo-adjuvant (N) | null | 2013-07-04 | Capecitabine 35days + RT | N | N | 230026041 | CAPECITABINE + OXALIPLATIN |
| 230000203 | 230000121 | 1.58 | 73.8 | Palliative (P) | null | 2016-06-16 | Capecitabine 35days + RT | null | N | 230026156 | OXALIPLATIN + MDG |
| 230000204 | 230001100 | 1.5 | 50.9 | Adjuvant (A) | 2016-11-28 | 2016-12-15 | Fluorouracil + Folinic Acid Weekly | 02 | N | 230026262 | CAPECITABINE + RT |
| 230000205 | 230000122 | 1.65 | 68 | Adjuvant (A) | 2013-04-02 | 2013-04-30 | CAPECITABINE + MITOMYCIN + RT | N | N | 230026283 | EOX |
| 230000206 | 230000122 | 1.86 | 68.9 | Adjuvant (A) | 2017-11-17 | 2017-12-07 | GEMCARBO | N | N | 230026283 | ECX |
| 230000208 | 230001102 | 1.6 | 52 | Adjuvant (A) | 2017-04-10 | 2017-04-26 | Irinotecan + Modified De Gramont | N | N | 230026412 | FLUOROURACIL |
| 230000209 | 230001102 | null | 94.6 | Adjuvant (A) | 2014-03-07 | 2014-04-22 | Capecitabine + Oxaliplatin 21day | N | N | 230026412 | OXALIPLATIN + MDG |
| 230000210 | 230000124 | 1.65 | 42 | Palliative (P) | 2018-06-25 | 2018-07-12 | Cisplatin + Pemetrexed | N | N | 230026444 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 230000211 | 230000125 | 1.84 | 84.7 | Palliative (P) | null | 2014-05-12 | Cisplatin + Doxorubicin | N | N | 230026534 | FLUOROURACIL |
| 230000212 | 230001103 | 1.6 | 145.8 | Adjuvant (A) | 2015-11-06 | 2015-11-25 | SCOT TRIAL | N | N | 230026618 | CAPECITABINE + OXALIPLATIN |
| 230000213 | 230001103 | 1.72 | 91.3 | Palliative (P) | null | 2014-04-13 | ESHAP | N | null | 230026618 | SORAFENIB |
| 230000214 | 230000126 | 1.85 | 70.1 | Palliative (P) | null | 2018-04-21 | Carboplatin + Docetaxel | null | null | 230026662 | CISPLATIN + GEMCITABINE |
| 230000215 | 230000127 | 1.42 | null | Palliative (P) | 2017-05-02 | 2017-05-22 | Cisplatin + Radiotherapy | 02 | N | 230026675 | CAPECITABINE |
| 230000217 | 230000129 | 1.55 | 48.2 | Adjuvant (A) | 2013-04-17 | 2013-05-02 | Capecitabine 35days + RT | N | null | 230026715 | CAPECITABINE + OXALIPLATIN |